Putting patients at the heart of clinical trials

‘Patient-centric’ trials have been a hot topic for several years, with a big emphasis on trial design. It is well known that putting patients at the heart of the clinical trials process can improve recruitment and retention rates [1], which is much needed considering that 85% of all clinical trials fail to recruit sufficient patients and 80% are delayed because of recruitment delays and high dropout rates [2]. Most recently, the COVID-19 pandemic has shone a light on the importance of diverse representation in clinical trials to make them more patient centric. The US FDA and the Pharmaceutical Research and...